Ads
related to: Acute Myeloid Leukemia- Info On Myelofibrosis
Learn About Myelofibrosis By
Viewing The Patient Site For More.
- Know The Side Effects
Explore The Risks And Side Effects
Of MF Treatment Option Today.
- View Myelofibrosis Info
Visit The Official Patient Site To
Learn About A Treatment Option.
- Find Out More On Savings
Learn About Options For Savings
And Resources On MF Treatment.
- Info On Myelofibrosis
Search results
MD Anderson Research Highlights: ASCO 2024 Special | Newswise
Newswise· 7 days agoThe University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These
Ayala Pharmaceuticals (NASDAQ:ADXS) Coverage Initiated by Analysts at StockNews.com
ETF DAILY NEWS· 3 days agoStockNews.com assumed coverage on shares of Ayala Pharmaceuticals (NASDAQ:ADXS – Free Report) in a research report sent to investors on Sunday morning. The firm issued a sell rating on the stock ...
The 3 Best Machine Learning Stocks to Quadruple Your Money by 2035
InvestorPlace· 6 days agoOne of the hottest investment trends to jump on at the moment is machine learning stocks to buy. Along the way, machines will learn from historical data, identify patterns, and make logical ...
MEI Pharma (NASDAQ:MEIP) Now Covered by Analysts at StockNews.com
ETF DAILY NEWS· 6 days agoStockNews.com assumed coverage on shares of MEI Pharma (NASDAQ:MEIP – Free Report) in a report issued on Thursday. The brokerage issued a buy rating on the stock. A number of other research ...
Swiss National Bank Trims Stake in Kura Oncology, Inc. (NASDAQ:KURA)
ETF DAILY NEWS· 2 days agoSwiss National Bank trimmed its stake in Kura Oncology, Inc. (NASDAQ:KURA – Free Report) by 16.1% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission ...
Actinium Pharmaceuticals, Inc. (NYSEAMERICAN:ATNM) Receives $25.60 Consensus Target Price from...
ETF DAILY NEWS· 6 days agoShares of Actinium Pharmaceuticals, Inc. (NYSEAMERICAN:ATNM – Get Free Report) have earned an average rating of “Buy” from the six brokerages that are presently covering the firm, MarketBeat ...
Assetmark Inc. Boosts Stock Position in BeiGene, Ltd. (NASDAQ:BGNE)
ETF DAILY NEWS· 4 days agoAssetmark Inc. boosted its holdings in shares of BeiGene, Ltd. (NASDAQ:BGNE – Free Report) by 13.4% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange ...
Small Business - Salisbury Post | Salisbury Post
The Salisbury Post· 1 day agoPomerantz LLP announces that a class action lawsuit has been filed against bluebird bio, Inc. (“bluebird” or the “Company”) (NASDAQ: BLUE). Such investors are advised to contact Danielle Peyton ...
Ads
related to: Acute Myeloid Leukemia
